{"count": 6, "results": [{"_id": "34347359", "pmid": 34347359, "title": "Metformin use and the risk of anal intraepithelial neoplasia in type II diabetic patients.", "journal": "Colorectal Dis", "authors": ["Hsu AT", "Hung YC", "Fang SH", "D'Adamo CR", "Mavanur AA", "Svoboda SM", "Wolf JH"], "date": "2021-12-01T00:00:00Z", "doi": "10.1111/codi.15860", "meta_date_publication": "2021 Dec", "meta_volume": "23", "meta_issue": "12", "meta_pages": "3220-3226", "score": 50264.016, "text_hl": "This relationship suggests that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could potentially play a protective role against @<m>DISEASE_Uterine_Cervical_Dysplasia</m> @DISEASE_MESH:D002578 @@@AIN@@@. ", "citations": {"NLM": "Hsu AT, Hung YC, Fang SH, D'Adamo CR, Mavanur AA, Svoboda SM, Wolf JH. Metformin use and the risk of anal intraepithelial neoplasia in type II diabetic patients. Colorectal Dis. 2021 Dec;23(12):3220-3226. PMID: 34347359", "BibTeX": "@article{34347359, title={Metformin use and the risk of anal intraepithelial neoplasia in type II diabetic patients.}, author={Hsu AT and Hung YC and Fang SH and D'Adamo CR and Mavanur AA and Svoboda SM and Wolf JH}, journal={Colorectal Dis}, volume={23}, number={12}, pages={3220-3226}}"}}, {"_id": "32085863", "pmid": 32085863, "title": "The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates.", "journal": "Gynecol Oncol", "authors": ["Acosta-Torres S", "Murdock T", "Matsuno R", "Beavis AL", "Stone RL", "Wethington SL", "Levinson K", "Grumbine F", "Ferriss JS", "Tanner EJ", "Fader AN"], "date": "2020-05-01T00:00:00Z", "doi": "10.1016/j.ygyno.2020.02.008", "meta_date_publication": "2020 May", "meta_volume": "157", "meta_issue": "2", "meta_pages": "348-356", "score": 50245.805, "text_hl": "The addition of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to progestin therapy in the fertility-sparing treatment of @SPECIES_9606 @@@women@@@ with @DISEASE_Endometrial_Hyperplasia @DISEASE_MESH:D004714 @@@atypical hyperplasia@@@/@<m>DISEASE_Uterine_Cervical_Dysplasia</m> @DISEASE_MESH:D002578 @@@endometrial intraepithelial neoplasia@@@ or @DISEASE_Endometrial_Neoplasms @DISEASE_MESH:D016889 @@@endometrial cancer@@@: Little impact on response and low live-birth rates.", "citations": {"NLM": "Acosta-Torres S, Murdock T, Matsuno R, Beavis AL, Stone RL, Wethington SL, Levinson K, Grumbine F, Ferriss JS, Tanner EJ, Fader AN. The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates. Gynecol Oncol. 2020 May;157(2):348-356. PMID: 32085863", "BibTeX": "@article{32085863, title={The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates.}, author={Acosta-Torres S and Murdock T and Matsuno R and Beavis AL and Stone RL and Wethington SL and Levinson K and Grumbine F and Ferriss JS and Tanner EJ and Fader AN}, journal={Gynecol Oncol}, volume={157}, number={2}, pages={348-356}}"}}, {"_id": "29211393", "pmid": 29211393, "pmcid": "PMC5815534", "title": "The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia", "journal": "Int Braz J Urol", "authors": ["Dell'Atti L", "Galosi AB"], "date": "2018-01-01T00:00:00Z", "doi": "10.1590/S1677-5538.IBJU.2017.0046", "meta_date_publication": "2018 Jan-Feb", "meta_volume": "44", "meta_issue": "1", "meta_pages": "69-74", "score": 50072.742, "text_hl": "The impact of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use on the risk of @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@ after prostate biopsy in @SPECIES_9606 @@@patients@@@ with high grade @<m>DISEASE_Uterine_Cervical_Dysplasia</m> @DISEASE_MESH:D002578 @@@intraepithelial neoplasia@@@", "citations": {"NLM": "Dell'Atti L, Galosi AB. The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia Int Braz J Urol. 2018 Jan-Feb;44(1):69-74. PMID: 29211393", "BibTeX": "@article{29211393, title={The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia}, author={Dell'Atti L and Galosi AB}, journal={Int Braz J Urol}, volume={44}, number={1}, pages={69-74}}"}}, {"_id": "28738823", "pmid": 28738823, "pmcid": "PMC5525317", "title": "Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer", "journal": "Mol Cancer", "authors": ["Chen K", "Qian W", "Jiang Z", "Cheng L", "Li J", "Sun L", "Zhou C", "Gao L", "Lei M", "Yan B", "Cao J", "Duan W", "Ma Q"], "date": "2017-07-24T00:00:00Z", "doi": "10.1186/s12943-017-0701-0", "meta_date_publication": "2017 Jul 24", "meta_volume": "16", "meta_issue": "1", "meta_pages": "131", "score": 50068.594, "text_hl": "However, following @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment, the percentage of early and late @<m>DISEASE_Uterine_Cervical_Dysplasia</m> @DISEASE_MESH:D002578 @@@mPanIN lesions@@@ was decreased (Fig. 2e). ", "citations": {"NLM": "Chen K, Qian W, Jiang Z, Cheng L, Li J, Sun L, Zhou C, Gao L, Lei M, Yan B, Cao J, Duan W, Ma Q. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer Mol Cancer. 2017 Jul 24;16(1):131. PMID: 28738823", "BibTeX": "@article{28738823, title={Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer}, author={Chen K and Qian W and Jiang Z and Cheng L and Li J and Sun L and Zhou C and Gao L and Lei M and Yan B and Cao J and Duan W and Ma Q}, journal={Mol Cancer}, volume={16}, number={1}, pages={131}}"}}, {"_id": "24466367", "pmid": 24466367, "title": "Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling.", "journal": "Transl Oncol", "authors": ["Mohammed A", "Janakiram NB", "Brewer M", "Ritchie RL", "Marya A", "Lightfoot S", "Steele VE", "Rao CV"], "date": "2013-12-01T00:00:00Z", "doi": "10.1593/tlo.13556", "meta_date_publication": "2013 Dec 1", "meta_volume": "6", "meta_issue": "6", "meta_pages": "649-59", "score": 50051.664, "text_hl": "We tested the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Uterine_Cervical_Dysplasia</m> @DISEASE_MESH:D002578 @@@pancreatic intraepithelial neoplasia@@@ (@<m>DISEASE_Uterine_Cervical_Dysplasia</m> @DISEASE_MESH:D002578 @@@PanIN@@@) and their progression to @DISEASE_Carcinoma_Pancreatic_Ductal @DISEASE_MESH:D021441 @@@PDAC@@@ in p48Cre/+.LSL-KrasG12D/+ transgenic @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Mohammed A, Janakiram NB, Brewer M, Ritchie RL, Marya A, Lightfoot S, Steele VE, Rao CV. Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling. Transl Oncol. 2013 Dec 1;6(6):649-59. PMID: 24466367", "BibTeX": "@article{24466367, title={Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling.}, author={Mohammed A and Janakiram NB and Brewer M and Ritchie RL and Marya A and Lightfoot S and Steele VE and Rao CV}, journal={Transl Oncol}, volume={6}, number={6}, pages={649-59}}"}}, {"_id": "31545922", "pmid": 31545922, "title": "Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity.", "journal": "Am J Physiol Gastrointest Liver Physiol", "authors": ["Dong TS", "Chang HH", "Hauer M", "Lagishetty V", "Katzka W", "Rozengurt E", "Jacobs JP", "Eibl G"], "date": "2019-12-01T00:00:00Z", "doi": "10.1152/ajpgi.00170.2019", "meta_date_publication": "2019 Dec 1", "meta_volume": "317", "meta_issue": "6", "meta_pages": "G763-G772", "score": 50043.28, "text_hl": "One potential way that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can affect the host is through alterations in the gut microbiome. ", "citations": {"NLM": "Dong TS, Chang HH, Hauer M, Lagishetty V, Katzka W, Rozengurt E, Jacobs JP, Eibl G. Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity. Am J Physiol Gastrointest Liver Physiol. 2019 Dec 1;317(6):G763-G772. PMID: 31545922", "BibTeX": "@article{31545922, title={Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity.}, author={Dong TS and Chang HH and Hauer M and Lagishetty V and Katzka W and Rozengurt E and Jacobs JP and Eibl G}, journal={Am J Physiol Gastrointest Liver Physiol}, volume={317}, number={6}, pages={G763-G772}}"}}]}